Champions Oncology targets sequential revenue growth and margin expansion as radiopharma and data platforms advance
Source: SeekingAlpha
2025-09-15 18:23:36 ET
More on Champions Oncology
- Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Champions Oncology
- Historical earnings data for Champions Oncology
- Financial information for Champions Oncology
Read the full article on Seeking Alpha
For further details see:
Champions Oncology targets sequential revenue growth and margin expansion as radiopharma and data platforms advance
Champions Oncology Inc.
NASDAQ: CSBR
CSBR Trading
-1.12% G/L:
$5.76 Last:
1,394 Volume:
$5.89 Open:
CSBR Latest News
March 05, 2026 04:00:00 pm
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
December 15, 2025 04:00:00 pm
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 08, 2025 04:00:00 pm
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
September 15, 2025 04:50:00 pm
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
CSBR Stock Data
$91,233,162
4,971,305
0.69%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Hackensack
